Reducing Risk in Hypertriglyceridemia REDUCEIT Trial

NEJMvideo
05 Jan, 2019 ,
No video provider was found to handle the given URL. See the documentation for more information.

Among patients with elevated triglyceride levels despite the use of statins the risk of ischemic events including cardiovascular death was significantly lower among those who received 2 g of icosapent ethyl twice daily than among those who received placebo

Source